This episode asks a bold and timely question: Should psychedelic-assisted therapy — using substances like psilocybin and MDMA — become a standard treatment for addiction? It’s a question that sits at the intersection of science, spirituality, and public policy, sparking both excitement and skepticism.

Together, we’ll explore a case study exploring these questions and listen to the voices and weigh the ethical and cultural challenges they present. Our aim is not to provide easy answers, but to open the conversation: could psychedelics reshape the future of recovery, or are we venturing into uncharted territory with risks we’ve yet to fully understand?

In this follow up episode to our prior episode we continue to explore the impacts and effects of harm reduction as it's being practiced in real time in a large urban area ,This episode seeks to look at the many issues associated with implementing a large scale harm reduction strategy in the treatment of individuals with addiction the article asks questions of our panel which investigate the impacts on local businesses, local law enforcement, local hospital based services and treatment facilities as well as the neighbors and families affected when a harm reduction strategy is implemented,

This episode focuses on the implementation and the controversies of a harm reduction strategy setup to curb addiction, overdoses and incarceration in a major urban area.